The European Commission publishes the Implementing Regulation (EU) 2024/3169 laying down detailed rules of procedure for joint scientific consultations on medicinal products for human use.
From 12 January 2025, the Implementing Regulation (EU) 2024/3169 will apply. The document sets out in detail the procedures for joint scientific consultations on medicinal products for human use at EU level under the Health Technology Assessment (HTA) Regulation, including:
- the submission of requests from health technology developers;
- the selection and consultation of stakeholder organisations and patients, clinical an other relevant experts;
- cooperation with the European Medicines Agency (EMA) where a health technology developer requests a joint scientific consultation to be carried out in parallel with EMA’s scientific advice process.